About the Salus Executive Team
William J. Hogan, ICD.D
President and CEO, and Chairman of the Board and Director
William J. Hogan is a highly motivated and results-oriented entrepreneur with more than 35 years of work experience in developing, operating, financing, and strategic planning for startup and growth level companies. He has held several senior executive positions at the chairman, ceo and president levels for several private companies. As well, Mr. Hogan’s extensive public company experience includes senior executive officer and director positions that provided a wealth of experience in many diverse industries. His corporate structuring skills with private and public companies include several successful transactions by acquisition, reverse takeover, and joint venture. Mr. Hogan’s professional development remains ongoing through his participation in numerous sales, securities, and marketing seminars.
He has completed the Directors Financial Literacy Program and holds the designation of ICD.D from the Institute of Corporate Directors. Mr. Hogan also holds the Canadian Securities Course certificate from the Canadian Securities Institute.
Peter Aldrich, CPA, CA
Chief Financial Officer
Peter Aldrich has more than 35 years of combined finance experience in public accounting, public and private companies, along with public sector and federal government positions. He holds the designations of Chartered Professional Accountant (CPA) and Chartered Accountant (CA) and obtained a Bachelor of Commerce Honours degree from Dalhousie University.
Throughout his professional career, Mr. Aldrich has held leadership roles ranging from senior audit manager, controller, executive director, and other managerial roles pertaining to financial reporting and project management in various industries and organizations including Deloitte, PwC, Government of Canada, Oilexco Incorporated, Alberta Health Services, Husky Energy, and Lone Pine Resources.
Robert J. Iverach, Q.C., ICD.D
Executive Vice President, Finance and Legal
Robert Iverach earned the degrees of Bachelor of Arts from the University of Calgary, a Bachelor of Law from the University of Alberta, and a Masters of Law from the London School of Economics. He has also been awarded the honorary distinction of Queen’s Counsel (Q.C.).
Mr. Iverach was a founding partner of Felesky Flynn LLP, a taxation law firm in Calgary and Edmonton, Alberta from which he retired in 2005 after 28 years. He is counsel with Burstall Winger Zammit LLP, a securities and corporate law firm in Calgary, Alberta.
He holds the designation of ICD.D from the Institute of Corporate Directors and is a past examiner for its Directors Education Program.
Executive Vice President, Sales and Product Development
Terry Macartney has more than 30 years’ laboratory and sales experience focused on expansion, upgrades, and strategy for several prominent medical and scientific companies. He holds degrees in Business Administration and a Post Graduate in Marketing. Mr. Macartney is a dual citizen of both the UK and Canada and has previously held president and ceo positions with various biotech companies including Starplex Scientific Inc., Vancouver Medical Laboratories Inc., and Sabre Scientific Inc. His most recent work for Sabre Scientific Inc. in Calgary was focused on business and product development for both biotech and medical device manufacturers, and he successfully expanded the markets across North America and Europe by increasing sales over $100 million in just under a decade.
Mr. Macartney’s ability to design major product groups has been utilized by sizable clients including Dynacare Kasper Laboratories Inc., UTI (University of Calgary), Plastique Gusselin of France, Starplex Scientific Inc., and Zephyr Sleep Technologies Inc.
He has held several current and past external executive positions and directorships, including the AHFMR Executive in Residence for the University of Calgary and Interim Executive Director for Biovantage Inc. in Calgary, Alberta.